FFP labor
Ended Purchase Order Awarded Last action
- Contract number
- N0018925PZ542
- Awardee
-
Pathoseq Bio, LLC UEI XZBGAKEK7K55
- Awarding agency
-
Naval Supply Systems Command
Department of the Navy, Department of Defense
- Obligated
- $247,497
Award facts
- Opportunity
-
- Bioinformatic Services Solicitation · N0018925RZ155 · Posted Sep 8, 2025
- Contract value 100% obligated
- $247,496.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Bureau of Medicine and Surgery Department of the Navy, Department of Defense
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Philippines
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $247,497 |
About this award
The Naval Supply Systems Command Fleet Logistics Center Philadelphia awarded a $247.5K firm fixed price purchase order to Pathoseq Bio, LLC on September 23, 2025, for bioinformatic services supporting NAMRU Indo-Pacific's biosurveillance initiatives across the Indo-Pacific Command Area of Responsibility. This contract, funded by the Bureau of Medicine and Surgery under the Department of the Navy, does not utilize any set-aside designation and was awarded without competition as a sole source contract based on Pathoseq Bio's unique Pan-Viral Panel technology. The contractor will provide critical capabilities for detecting biothreat agents, arboviruses, and antibiotic-resistant organisms through standardized laboratory procedures and consensus genome development, with work performance extending through September 22, 2026.
Pathoseq Bio will support existing health facilities and infectious disease surveillance networks across Malaysia, Laos, Vietnam, the Philippines, South Korea, Taiwan, and Papua New Guinea by leveraging their proprietary Pan-Viral Panel compatible with Oxford Nanopore Technologies MinION sequencing devices. The company's specialized expertise in genomic analysis and biothreat detection, demonstrated through consistent contract awards from the Navy ranging from $155K to $248K, positions it as the sole qualified source for this critical medical research and development effort. Primary performance will occur on the West Coast of the United States, with potential wet-lab training and sample processing at partner locations throughout the region.
Quick answers
Who was awarded contract N0018925PZ542?
N0018925PZ542 was awarded to Pathoseq Bio, LLC by Naval Supply Systems Command (Department of the Navy) on September 23, 2025.
How much is contract N0018925PZ542 worth?
The government has obligated $247,497 on N0018925PZ542.
Which agency awarded contract N0018925PZ542?
Naval Supply Systems Command (Department of the Navy) awarded N0018925PZ542, with funding from Bureau of Medicine and Surgery (Department of the Navy).
Was contract N0018925PZ542 competed?
The extent of competition for N0018925PZ542 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award